学习园地

Magstim 里程碑分享：Horizon 3.0 系统结合 StimGuide Pro 神经导航正式获欧盟 MDR 批准，并已投入 TMS 治疗

发布时间：2025-12-19 15:08:28   来源：本站   点击：11次

　　Magstim 荣幸地宣布一项重大里程碑：配备 StimGuide Pro 神经导航的 Magstim Horizon 3.0 系统已正式获得欧盟医疗器械法规 (MDR) 批准，目前正被欧盟客户用于经颅磁刺激 (TMS) 治疗。

　　欧洲首装：Horizon 3.0 + StimGuide Pro 落户 Basalt

　　Magstim 与合作伙伴 Neurostim 携手，已在荷兰海牙和莱顿的 Basalt 康复中心成功完成了 Horizon 3.0 + StimGuide Pro 系统在欧洲的首批安装。

　　这些先进的系统将成为由乌得勒支大学医学中心牵头的大规模临床试验——"B-STARS2 研究（脑刺激促进卒中后手臂功能恢复）"的核心组成部分。该研究旨在探索重复经颅磁刺激 (rTMS) 在改善卒中后运动功能方面的治疗潜力。

　　欧洲首批 Horizon 3.0 + StimGuide Pro 系统安装

　　支持精准引导的经颅磁刺激 (TMS) 用于卒中后手臂恢复

　　成为神经康复领域一项里程碑式临床研究的关键组成部分MDR 批准：对我们的客户意味着什么

　　随着 MDR 认证的获得，Magstim 可以满怀信心地按计划在全欧洲推进 Horizon 3.0 的交付工作。我们正在积极协调发货，并安排更多的系统安装。

　　此项批准不仅证实了我们系统的安全性、临床价值和技术卓越性，也加速了临床医生和研究人员获取此项基于证据、精准引导的脑刺激技术的进程。

　　精准引导。可靠复现。突破创新。

　　Magstim Horizon 3.0 系统与 StimGuide Pro 专为现代神经刺激工作流程打造：

　　神经导航技术，提升靶向定位精度

　　实现跨治疗周期的可靠线圈定位

　　增强临床信心与治疗一致性我们衷心感谢 Basalt 团队、Neurostim 团队、乌得勒支大学医学中心团队以及全球 Magstim 社区，正是大家的共同努力，才将这项技术带到了最需要它的患者身边。

　　这仅仅是一个开始，更多的安装即将到来。

　　Magstim is proud to share a major milestone: the Magstim Horizon 3.0 system with StimGuide Pro neuro-navigation has officially received MDR (Medical Device Regulation) approval and is being used by customers in the EU for Transcranial Magnetic Stimulation (TMS).

　　A European First: Horizon 3.0 + StimGuide Pro Installed at Basalt

　　In partnership with Neurostim, Magstim has successfully completed the first European installations of the Horizon 3.0 + StimGuide Pro systems at Basalt Rehabilitation Centres in The Hague and Leiden, Netherlands.

　　These advanced systems will play a central role in the B-STARS2 study (Brain STimulation for Arm Recovery after Stroke) — a large-scale clinical trial led by UMC Utrecht. The study explores the therapeutic potential of repetitive transcranial magnetic stimulation (rTMS) in improving motor function after stroke.

　　First Horizon 3.0 + StimGuide Pro installations in Europe

　　Supporting precision-guided Transcranial Magnetic Stimulation (TMS) for post-stroke arm recovery

　　Key component in a landmark clinical study in neurorehabilitation

　　MDR Approval: What It Means for Our Customers

　　With MDR certification now secured, Magstim can confidently move forward with scheduled Horizon 3.0 deliveries across Europe. We’re actively coordinating shipments and scheduling more installations.

　　This approval not only affirms the safety, clinical value, and technical excellence of our system — it also accelerates access for clinicians and researchers pursuing evidence-based, precision-guided brain stimulation.

　　Guided. Repeatable. Revolutionary.

　　The Magstim Horizon 3.0 with StimGuide Pro is purpose-built for modern neurostimulation workflows:

　　Neuro-navigation for enhanced targeting precision

　　Repeatable coil placement across sessions

　　Improved clinical confidence and treatment consistency

　　We thank the teams at Basalt, Neurostim, UMC Utrecht, and our global Magstim community for helping bring this technology to patients where it matters most.

　　This is only the beginning. More installations are on the horizon.To find out more about Magstim Horizon, please click here: https://www.magstim.com/horizon-tms/

　　Marketing Doc No: MK2410 -01